Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.62M | -9.04M | -18.30M | -20.94M | -6.18M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 111.70K |
| Total Other Non-Cash Items | 1.85M | 1.13M | 3.83M | 15.51M | 341.50K |
| Change in Net Operating Assets | 2.79M | -1.06M | 626.60K | -1.34M | 254.00K |
| Cash from Operations | -6.98M | -8.97M | -6.61M | -6.76M | -5.47M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -4.62M | -- |
| Cash from Investing | -- | -- | 0.00 | -4.62M | -- |
| Total Debt Issued | 22.00M | -- | 0.00 | 7.37M | 4.50M |
| Total Debt Repaid | -2.35M | -3.18M | -1.75M | -5.64M | -- |
| Issuance of Common Stock | 6.49M | 10.01M | 8.48M | 9.01M | 6.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -615.00K | -- | -69.10K | -368.70K | -327.40K |
| Cash from Financing | 25.53M | 6.83M | 6.65M | 10.37M | 11.16M |
| Foreign Exchange rate Adjustments | 279.60K | -195.10K | -1.20K | -1.70K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.83M | -2.34M | 43.10K | -1.01M | 5.69M |